.jpg)
Today, the shares of Galenica Santé AG (“Galenica Santé”) were listed and traded for the first time under the “International Reporting Standard” of SIX Swiss Exchange, opening at CHF 43.00. This corresponds to a total market capitalization of CHF 2.15 billion.
The issued share capital of Galenica Santé comprises 50,000,000 ordinary registered shares with a nominal value of CHF 0.10 per share.
The IPO consists of 42,391,300 ordinary registered shares plus an overallotment option, granted to the banking consortium, of up to 6,358,700 shares. At the offering price of CHF 39.00, the placement volume amounts to CHF 1.90 billion including the overallotment option, the largest IPO in Europe year to date.
The already listed Galenica AG (new ticker symbol VIFN) will receive the entire net proceeds from the sale of the offered shares.
Galenica Santé is the leading fully-integrated healthcare provider in Switzerland. With nearly 500 own, joint venture and independent partner pharmacies, Galenica Santé operates the largest network of pharmacies in Switzerland. In addition, Galenica Santé further develops and offers well-known own brands and products, exclusive brands and products from business partners as well as a variety of on- site health services and tests for customers. Galenica Santé is also the leading provider of pre- wholesale and wholesale distribution as well as database services in the Swiss healthcare market.
